Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending November 09, 2005. The document serves as a notification of transactions involving Directors, Persons Discharging Managerial Responsibility, or Connected Persons regarding their interests in the company's Ordinary Shares.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is strictly a disclosure of share transactions and does not contain financial performance data.
Material Changes
The filing details the acquisition of Ordinary Shares by four individuals under the Company's ShareReward Plan on November 09, 2005. The shares were purchased at a price of GBP15.30 per Ordinary Share. The transactions involved:
- Mr J S Heslop
- Mr R Bondy
- Mr A P Witty
- Mrs J V Younger
Each individual acquired 8 Ordinary Shares through the partnership element (personal contribution) and 8 Ordinary Shares through the matching element (Company contribution).
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is limited to the statutory notification of the share purchases described above.
Key Facts for Investor Verification
- Transaction Date: November 09, 2005
- Share Price: GBP15.30 per Ordinary Share
- Participants: Four senior individuals (Heslop, Bondy, Witty, Younger)
- Volume: 16 shares per individual (8 personal, 8 company-matched)
- Plan Details: Transactions executed under the ShareReward Plan entered into on October 05, 2001